#United States #Radnor #Kessler Topaz Meltzer #TransMedics Group #Investors Alert

Investigation of TransMedics Group, Inc.

In recent developments, prominent law firm Kessler Topaz Meltzer & Check, LLP has initiated an investigation into possible federal securities law violations by TransMedics Group, Inc. (NASDAQ: TMDX). On January 10, 2025, a short seller report released by Scorpion Capital raised serious allegations against the medical technology company, focusing on its operational practices. The report claims that TransMedics has engaged in questionable billing methods, misuses of its devices outside of approved indications, and unethical sales incentives. Additionally, it noted ongoing scrutiny from significant regulatory bodies including the Department of Justice (DOJ), the Internal Revenue Service (IRS), and various state attorneys general related to potential Medicare fraud involving organ acquisition costs.

Furthermore, the report cited evidence of customer dissatisfaction with TransMedics’ technology, claiming that several leading transplant centers have ceased using their devices due to concerns about their clinical effectiveness. In light of these serious allegations, the company’s stock price has suffered, plummeting over 13% in the wake of the report.

This inquiry aims to help investors who may have incurred significant financial losses as a result of these allegations against TransMedics. Investors who believe they have been affected by these developments are encouraged to get in touch with Kessler Topaz Meltzer & Check, LLP to learn more about their rights and potential recovery options. The firm specializes in litigating class actions relating to securities fraud and breaches of fiduciary duties across both state and federal courts.

Kessler Topaz Meltzer & Check, LLP has a proven track record of advocating for corporate governance reforms and has successfully recovered billions of dollars for both individual and institutional investors worldwide. Aside from serving investors, the firm also represents consumers and whistleblowers, providing them with a legal platform to report fraudulent activities within businesses.

For those interested in participating, Kessler Topaz Meltzer & Check, LLP has made it easy to engage. Potential claimants are urged to complete an online form available on the firm's website or reach out directly via phone or email. Legal representatives from the firm, including Jonathan Naji, Esq., are poised to assist affected investors.

As the investigation progresses, stakeholders will undoubtedly be keeping a close eye on both TransMedics' market performance and the potential legal ramifications that may emerge from this inquiry. Investors seeking to safeguard their interests during uncertain times would do well to remain informed and proactive.

For further inquiries, please visit www.ktmc.com or contact the firm directly at the following:

• - Contact: Jonathan Naji, Esq.
• - Phone: (484) 270-1453
• - Email: [email protected]

This investigation serves as a timely reminder for investors to scrutinize the practices of companies they are investing in and remain vigilant against potential securities fraud. The initiation of such investigations demonstrates the ongoing commitment to uphold investor rights and ensure ethical corporate practices.